Total Payments
$1,037
2024 Payments
$164.59
Companies
9
Transactions
55
Payment Breakdown by Category
Food & Beverage$1,037 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,037 | 55 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $326.23 | 20 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $207.08 | 14 | $0 (2024) |
| Alkermes, Inc. | $136.65 | 3 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $88.81 | 5 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $84.52 | 4 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $80.28 | 4 | $0 (2024) |
| Janssen Biotech, Inc. | $51.04 | 2 | $0 (2023) |
| Lundbeck LLC | $49.59 | 2 | $0 (2024) |
| Novo Nordisk Inc | $12.58 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $164.59 | 8 | Supernus Pharmaceuticals, Inc. ($60.32) |
| 2023 | $390.30 | 16 | Alkermes, Inc. ($136.65) |
| 2022 | $402.46 | 26 | ABBVIE INC. ($159.10) |
| 2021 | $79.43 | 5 | AbbVie Inc. ($40.19) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $29.45 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: PSYCHIATRY | ||||||
| 08/29/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Neurology | ||||||
| 08/06/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/08/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 06/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 03/25/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Central Nervous System | ||||||
| 01/17/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Neurology | ||||||
| 12/11/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: CNS | ||||||
| 10/30/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $108.09 | General |
| Category: CNS | ||||||
| 10/09/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.93 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2023 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 09/13/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $19.96 | General |
| Category: PSYCHOLOGY | ||||||
| 09/11/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: CNS | ||||||
| 09/01/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), REXULTI | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: PSYCHIATRY | ||||||
| 08/31/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2023 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 08/17/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.81 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: PSYCHIATRY | ||||||
| 04/06/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Neuropsychiatry | ||||||
| 02/23/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: PSYCHIATRY | ||||||
About Clement Efobi, APRN
Clement Efobi, APRN is a Case Manager/Care Coordinator healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2019. The National Provider Identifier (NPI) number assigned to this provider is 1952943037.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Clement Efobi, APRN has received a total of $1,037 in payments from pharmaceutical and medical device companies, with $164.59 received in 2024. These payments were reported across 55 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,037).
Ad
Practice Information
- Specialty Case Manager/Care Coordinator
- Other Specialties Psychiatric/Mental Health
- Location Washington, DC
- Active Since 10/10/2019
- Last Updated 08/14/2023
- Taxonomy Code 171M00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1952943037
Products in Payments
- VRAYLAR (Drug) $326.23
- ABILIFY MAINTENA (Drug) $133.48
- LYBALVI (Drug) $108.09
- REXULTI (Drug) $89.81
- INGREZZA (Drug) $88.81
- Qelbree (Drug) $60.32
- SYMTUZA (Drug) $51.04
- UZEDY (Drug) $40.33
- ABILIFY ASIMTUFII (Drug) $33.38
- ARISTADA (Drug) $28.56
- AUSTEDO (Drug) $24.99
- QELBREE (Drug) $19.96
- Austedo XR (Drug) $19.20
- Ozempic (Drug) $12.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Case Manager/Care Coordinator Doctors in Washington
Eumeka Smallwood-Griffin
Case Manager/Care Coordinator
Case Manager/Care Coordinator
Mr. Onoisewealu Osunbor
Case Manager/Care Coordinator
Case Manager/Care Coordinator
Miss. Elizabeth Mohler, Licsw, LICSW
Case Manager/Care Coordinator
Case Manager/Care Coordinator
Mrs. Kelly Fagan-Dyer, Lsw, LSW
Case Manager/Care Coordinator
Case Manager/Care Coordinator
Miss. Anitra Sivels
Case Manager/Care Coordinator
Case Manager/Care Coordinator
Mrs. Jacqurie Frye Adams
Case Manager/Care Coordinator
Case Manager/Care Coordinator